SINOVAC BIOTECH LTD. - Common Shares (SVA)

Q3 2024 13F Holders as of 9/30/2024

Type / Class: Equity / Common Shares
Shares outstanding: 71.9M
Number of holders: 4
Total 13F shares, excl. options: 14.8M
Shares change: -1.38M
Total reported value, excl. options: $418M
Value change: -$1.19M
Number of sells: -7
Price: $6.47

Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q3 2024

11 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q3 2024.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14.8M shares of 71.9M outstanding shares and own 20.64% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (11.8M shares), ORBIMED ADVISORS LLC (2.72M shares), Neumann Advisory Hong Kong Ltd (316K shares), Horizon Investments, LLC (52 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares), GROUP ONE TRADING LLC (0 shares), RENAISSANCE TECHNOLOGIES LLC (0 shares), MORGAN STANLEY (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), and WELLS FARGO & COMPANY/MN (0 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.